Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

MCC-565 prevents bone loss due to estrogen deficiency in monkeys

Oct. 6, 2000

Lasofoxifene's bone protective effects tested in multiple studies

Oct. 6, 2000

Bone strength, density improved by LY-353381 in ovariectomized rats

Oct. 6, 2000

Intranasal apomorphine phase I results reported

Oct. 6, 2000

Increased bone formation associated with Fra-1 and deltaFosB overexpression in transgenic mice

Oct. 6, 2000

Beneficial effects of Ro-26-9228 on bone coupled with minimal effects on Ca homeostasis

Oct. 5, 2000

New inhibitor of cathepsin K and bone resorption reduces bone turnover in primate model

Oct. 5, 2000

First prescription drug to treat unwanted facial hair introduced in U.S.

Oct. 5, 2000

SB presents cathepsin K inhibitors and their use

Oct. 5, 2000

More potential GH secretagogues patented by Lilly

Oct. 5, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 8, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
Autobahn on the fast track with bipolar thyroid agonist
BioWorld
Achieving high marks in the phase II Amplify-BD trial for bipolar I and II depression, Autobahn Therapeutics Inc.’s elunetirom, a brain-penetrant central nervous...